Skip to main content

Coronavirus (COVID-19) Updates: Visitation Policies (New! 11.25.20) | How We're Keeping You Safe | Latest COVID Information

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
URMC / Research / Clinical Trials / Study Details

Effects of Nutrition and Exercise on Chemotherapy Induced Neuropathy

Research Question:
What are the effects of exercise and nutrition interventions during chemotherapy on chemotherapy-induced peripheral neuropathy (CIPN).

Basic Study Information

Purpose:
Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and severe side-effect of taxane chemotherapy, often used to treat breast cancer. Unfortunately there are very limited treatments for CIPN. This is a phase II randomized controlled trial to test the preliminary efficacy of exercise vs. nutrition education on CIPN, to systematically investigate the potential roles of inflammation and interoception, and to obtain data with a more accurate effect size to inform a future study.

Location: University of Rochester Medical Center
Study Reference #: STUDY00003387

Lead Researcher (Principal Investigator)

Lead Researcher:  Ian Kleckner

Study Contact Information

Study Coordinator: Nicole Murray
Phone: +1 585-276-4638
Email: nicole_murray@urmc.rochester.edu

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search